Alnylam Pharmaceuticals | ALNY - Ebitda





Ebitda Alterar Data
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amgen USD 3.86B 1.28B 2026-03
Arrowhead Research USD -147.68M 40.33M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.41B 431M 2026-03
PTC Therapeutics USD 61.98M 132.97M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sanofi EUR 2.72B 2.94B 2026-03
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Takeda JPY 364.46B 214.21B 2026-06
Tectonic Therapeutic USD -21.18M 365K 2025-12
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06
Xencor USD -34.63M 86.74M 2026-06